Start Page

T Patras : +30 2610 223999 / T Athens: +30 210 2751602T Thessaloniki+30 2316 019079

DCA Vantage® Analyzer
Click to enlarge

The DCA Vantage® Analyzer helps you monitor glycemic control and detect early kidney disease in environments ranging from the physician’s office to remote, point-of-care coordinated sites in hospitals and multisite practices. Meet lab-quality testing standards with an analyzer that speeds and simplifies diabetes tests and delivers accurate, clinically relevant results shown to improve decision-making, patient compliance, and outcomes.

Fast, actionable test results enable you to determine the effectiveness of a treatment plan, make therapeutic adjustments with confidence, and be more certain whether patients are complying with your recommendations.

 Monitor glycemic control

  • HbA1c from a small (1 µL) whole blood sample in 6 minutes
  • Flexible reporting of HbA1c% (NGSP, JDS, and Mono-S units) and IFCC (mmol/mol)
  • Reporting of HbA1c results as Estimated Average Glucose values* in the same units (mg/dL) that patients’ home glucose meters display
  • HbA1c patient trending graphs can be viewed or printed

Detect early kidney disease

  • Albumin, Creatinine, and Albumin-to-Creatinine (A:C) ratio from a urine specimen in 7 minutes to report a quantitative protein status with automatic creatinine adjustment
  • Onboard GFR calculator indexes kidney function

Improve workflow in the office or clinic

  • Self-contained cartridges facilitate easy, walkaway operation after sample loading
  • No sample or reagent preparation required
  • Bar-code scanner for safer and faster patient/operator ID entry
  • Review results on-screen or generate a hard copy report to minimize transcription errors in the office
  • Convenient local storage of up to 4,000 onboard records with powerful sorting capabilities
  • Automatically upload results to a PC via a USB flash drive to reduce manual logging and save time
  • Minimal maintenance requirements with automatic reminders to alert you when maintenance is due

Simplify management of diabetes testing in decentralized settings

  • Customizable security access modes support up to 1,000 operators, protect patient information, and prevent operation by unauthorized users
  • POCT1-A2 communication protocol streamlines data transfer for easy connectivity and fast, two-way communication to LIS/HIS, RAPIDComm® System, or other third-party POC data management systems
  • Automatically upload results and QC information to LIS/HIS to reduce manual logging and save time
  • Take testing oversight to the next level with RAPIDComm Data Management System to remotely manage multiple analyzers and operators to enhance compliance and improve risk management. POC coordinators can standardize test procedures, enforce QC protocols, control access privileges, define operator recertification requirements, and more. Customized alerts, reports, and audit trails ensure peace of mind and simplify accreditation and inspections


Formulas for Calculated Results
% HbA1c = (HbA1c/Total Hemoglobin) x 100

eAG* mg/dL = (28.7 x HbA1C) – 46.7
eAG* mmol/L = (1.59 x HbA1C) – 2.59
GFR = 186 x (plasma creatinine mg/dL)-1.154 x (patient age years)-0.203 x (0.742 if female patient) x (1.210 if African American patient)

Formulas for Dual Reporting From IFCC to % HbA1c
NGSP = (0.09148 x IFCC) + 2.152
JDS = (0.09274 x IFCC) +1.724
Mono-S = (0.09890 x IFCC) + 0.884

Formulas for Dual Reporting From % HbA1c to IFCC mmol/mol
IFCC = (10.93 x NGSP) – 23.50
IFCC = (10.78 x JDS) – 18.59
IFCC = (10.11 x Mono-S) – 8.94 

Technical Specifications


System Description Point-of-care immunoassay analyzer
Quantitative Tests Hemoglobin A1c (whole blood): Range: 2.5% to 14% (4mmol/mol to 130 mmol/mol) Microalbumin/Creatinine (urine): Single test reports all three results for: Albumin: 5 to 300 mg/L; Creatinine: 15 to 500 mg/dL (1.3 to 44.2 mmol/L); Albumin-to Creatinine Ratio: 1 to 2000 mg/g (0.11 to 226 mg/mmol)
Test Format Self-contained immunoassay cartridges
Test Measurement Automatic, optional transmission
Test Method HbA1c: monoclonal antibody agglutination reaction
Albumin: polyclonal goat anti-human albumin antiserum
Creatinine: Benedict Behre chemical reaction
Time to Test Results HbA1c - 6 minutes
  A:C Ratio - 7 minutes

Test Handling  
Sample Volume HbA1c - 1µL whole blood
Microalbumin/Creatinine - 40µL urine
Sample Preparation No pretreatment; no pipetting required
Sample ID/Operator ID Entry Optional; via touch screen or bar code reader



Lot-specific calibration card provides automatic calibration with every cartridge

Traceable to International Federation of Clinical Chemistry (IFCC) reference materials and test methods for measurement of HbA1c


Onboard Computer  
Storage Capacity/Memory 4000 patient and/or control records
Up to 1,000 operator IDs
Display Color touch screen with 1/4 VGA resolution
Data Export Via USB flash drive to PC or direct to LIS/HIS or data manager, if interfaced

Quality Control/Compliance  
Flexible QC Scheduling None, Automatic Reminders or Required
QC Testing Optional lockout if schedule not followed or QC fails
User/Operator Access Restricted, if desired, to protect patient and QC data and prevent unauthorized use
Matching Lab Results/
Reference Method

Adjustable correlation to reference methods
Reference Ranges User-definable reference ranges available for HbA1c

9.0 (h) x 11.5 (w) x 10.5 (d) inches 25.4 (h) x 28.7 (w) x 27.7 (d) cm


3.88 kg (9.0 lb)

Power Requirements

100 to 240 VAC; 50/60 Hz

Line Leakage Current

<0.3 mA in normal condition
<0.5 mA in single fault condition

Maximum Power Input

70 VA; 30 watts

Ambient Operating Temperature

18°C to 30°C (64°F to 86°F) (Albumin)
15°C to 32°C (61°F to 88°F) (HbA1c)

Operating Temperature

5°C to 40°C (41°F to 104°F);
15% to 90% relative humidity


TUV SUD with CB Scheme, CSA-C22.2,
EN60601, IEC 60601, UL60601

EMC Emissions/Immunity

FCC 47: Part 15 (Class B),
EN60601-1-2 (Class B)



Contact Form



Contact us

         195 Panepistimiou str., PC 26443, Patras, Greece
Τ Patras: +30 2610 223999
Τ Athens: +30 210 2751602
     Τ Thessaloniki: +30 2316 019079

Login / Sitemap

Copyright © 2013 - 2024 VAKTRO SCIENTIFIC